{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:27:01Z","timestamp":1777858021679,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[1989,7,1]],"date-time":"1989-07-01T00:00:00Z","timestamp":615254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[1989,7]]},"abstract":"<jats:p>Investigations into antimotion sickness drugs fall into two main categories: efficacy ('benefits') and side-effects ('costs'). This study was of the second type. Oral cinnarizine (30 mg: normal dose; and 75 mg: 2.5 x normal dose) and placebo, were investigated using a battery of automated mental, motor, physiological and other tests in twelve young healthy male volunteers. The higher cinnarizine dose level was chosen to exaggerate effects and make it easier to track them. Oral hyoscine (1.2 mg: 2 x normal dose) was employed as a positive internal control. Side-effects were almost exclusively due to hyoscine whereas cinnarizine was almost free of significant effects even at the higher dose of 75 mg. Hyoscine impaired performance 1-3 hours postdrug, whereas the effects of cinnarizine occurred approximately 5-7 hours postdrug. This paralleled the slower time-course for the protective action of cinnarizine against motion sickness noted in earlier studies. These results, taken in conjunction with previous trials, suggest that oral cinnarizine would seem less likely than hyoscine to produce unwanted decrements in performance.<\/jats:p>","DOI":"10.1177\/026988118900300401","type":"journal-article","created":{"date-parts":[[2007,3,17]],"date-time":"2007-03-17T23:45:17Z","timestamp":1174175117000},"page":"187-197","source":"Crossref","is-referenced-by-count":3,"title":["Time-course of effects of oral cinnarizine and hyoscine on task performance"],"prefix":"10.1177","volume":"3","author":[{"given":"J.F.","family":"Golding","sequence":"first","affiliation":[{"name":"Institute of Naval Medicine, Alverstoke, Gosport, Hants PO12 2DL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Strong","sequence":"additional","affiliation":[{"name":"Institute of Naval Medicine, Alverstoke, Gosport, Hants PO12 2DL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Pethybridge","sequence":"additional","affiliation":[{"name":"Institute of Naval Medicine, Alverstoke, Gosport, Hants PO12 2DL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1989,7,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.2466\/pms.1986.63.2.683"},{"key":"atypb2","first-page":"895","volume":"18","author":"Brand J.J.","year":"1966","journal-title":"Pharmacological Reviews"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3932(88)90004-8"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600671010"},{"key":"atypb5","unstructured":"Declaration of Helsinki (1975) 'Adopted by the 18th World Medical Assembly, Helsinki, Finland (1964) and As Revised by the 29th World Medical Assembly, Tokyo, Japan (1975)'. In: Proposed International Guidelines for Biomedical Research Involving Human Subjects, pp. 35-40, WHO\/CIOMS, Geneva (1982)"},{"key":"atypb6","volume-title":"Aviation medicine. Health and clinical aspects","author":"Dhenim G.","year":"1978"},{"key":"atypb7","volume-title":"Unified Tri-service Cognitive Performance Assessment Battery (UTC-PAB) (Rep. No. 86-1)","author":"Englund C.E.","year":"1986"},{"key":"atypb8","first-page":"27","volume":"18","author":"Godfraind T.","year":"1982","journal-title":"Drugs of Today"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428903"},{"key":"atypb10","first-page":"184","volume":"13","author":"Herxheimer A.","year":"1958","journal-title":"British Journal of Pharmacology"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)81721-1"},{"key":"atypb12","unstructured":"Jennings J.R., Tahmoush A.J., Redmond D.P. 1980 Non-invasive measurement of peripheral vascular activity In: Techniques in psychophysiology. (Eds Martin I, Venables P H), pp 69-137, John Wiley & Sons, Chichester"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1988.tb02691.x"},{"key":"atypb14","volume-title":"Automated portable test system (APTS): a performance envelope tool","author":"Kennedy R.S.","year":"1985"},{"key":"atypb15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00421398","volume":"28","author":"Ketchum J.S.","year":"1973","journal-title":"Psychopharmacologia"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00944.x"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(83)80048-X"},{"key":"atypb18","first-page":"218","volume":"58","author":"Oosterveld W.J.","year":"1987","journal-title":"Aviation Space and Environmental Medicine"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1007\/BF00174373"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470010209"},{"key":"atypb21","volume-title":"The effects of single and repeated doses of oral hyoscine (scopolamine), cinnarizine, and placebo, upon psychological performance and physiological functioning","author":"Parrott A.C.","year":"1988"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1007\/BF00176487"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196232184"},{"key":"atypb24","volume-title":"A double blind placebo controlled comparison of early administered cinnarizine in increasing tolerance to a nauseogenic cross-coupled motion challenge. INM Report 24\/87","author":"Pingree B J W","year":"1988"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1080\/01483918408068873"},{"key":"atypb26","volume-title":"A double blind comparative trial of powdered ginger root, hyoscine hydrobromide, and cinnarizine in the prophylaxis of motion sickness induced by cross-coupled stimulation. AGARD Symposium Proceedings","author":"Stott J R R","year":"1984"},{"key":"atypb27","volume-title":"Cinnarizine and performance. MS Trial No. 7. Unpublished","author":"Strong R.","year":"1982"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100089787"},{"key":"atypb29","volume-title":"Cambridge low contrast gratings: instructions for use","author":"Wilkins A.J.","year":"1987"},{"key":"atypb30","first-page":"310","volume":"56","author":"Wood C.D.","year":"1985","journal-title":"Aviation Space and Environmental Medicine"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988118900300401","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988118900300401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:06:11Z","timestamp":1777507571000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026988118900300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["10.1177\/026988118900300401"],"URL":"https:\/\/doi.org\/10.1177\/026988118900300401","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}